Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details